Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype
- 1 December 1997
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 239 (1) , 33-36
- https://doi.org/10.1016/s0304-3940(97)00872-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Apolipoprotein E, Plaques, Tangles and Cholinergic Dysfunction in Alzheimer's DiseaseaAnnals of the New York Academy of Sciences, 1996
- Memory deficits and cholinergic impairments in apolipoprotein E-deficient miceNeuroscience Letters, 1995
- Apolipoprotein E in animal models of CNS injury and in alzheimer's diseaseTrends in Neurosciences, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brainNeurobiology of Aging, 1992
- Apolipoprotein E genotyping by one-stage PCRThe Lancet, 1991
- ALZHEIMER'S DISEASE AS A DISORDER OF ISODENDRITIC COREThe Lancet, 1982
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975